Opaleye Management Inc. 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Opaleye Management Inc. disclosed 54 US equity positions worth $759.2m in its Q1 2026 13F filing. The largest position was HROW at 13.2% of the reported book, followed by LQDA and ETON.
What did Opaleye Management Inc. own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | HROW HARROW INC | 13.2% | $99.9m | 2,832,230 | – | ||
| 2 | LQDA LIQUIDIA CORPORATION | Healthcare | 11.7% | $88.8m | 2,545,000 | – | |
| 3 | ETON ETON PHARMACEUTICALS INC | 9.3% | $70.6m | 2,860,000 | – | ||
| 4 | SOL-GEL TECHNOLOGIES LTD | 5.2% | $39.6m | 500,000 | – | ||
| 5 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 4.7% | $35.3m | 123,000 | – | |
| 6 | APGE APOGEE THERAPEUTICS INC | Healthcare | 4.3% | $32.8m | 390,000 | – | |
| 7 | IRON DISC MEDICINE INC | Healthcare | 3.5% | $26.9m | 421,000 | – | |
| 8 | URGN UROGEN PHARMA LTD | Healthcare | 3.4% | $25.7m | 1,430,000 | – | |
| 9 | CBIO CRESCENT BIOPHARMA INC. | 3.2% | $24.1m | 1,312,615 | – | ||
| 10 | STOK STOKE THERAPEUTICS INC | Healthcare | 3.0% | $22.8m | 700,000 | – | |
| 11 | CATX PERSPECTIVE THERAPEUTICS INC | 2.6% | $19.5m | 4,675,000 | – | ||
| 12 | RZLT REZOLUTE INC | 2.5% | $19.2m | 6,300,000 | – | ||
| 13 | MGTX MEIRAGTX HLDGS PLC | Healthcare | 2.4% | $18.4m | 2,123,259 | – | |
| 14 | TGTX TG THERAPEUTICS INC | Healthcare | 2.3% | $17.8m | 535,000 | – | |
| 15 | SANUWAVE HEALTH INC | 2.2% | $17.0m | 981,267 | – | ||
| 16 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 2.1% | $15.8m | 500,000 | – | |
| 17 | ALPHA COGNITION INC | 1.9% | $14.1m | 2,561,950 | – | ||
| 18 | ANNX ANNEXON INC | Healthcare | 1.7% | $12.9m | 2,331,761 | – | |
| 19 | ALMS ALUMIS INC | Healthcare | 1.6% | $12.1m | 550,000 | – | |
| 20 | CDXS CODEXIS INC | Healthcare | 1.5% | $11.1m | 6,785,000 | – | |
| 21 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.4% | $10.5m | 100,000 | – | |
| 22 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.3% | $9.7m | 100,000 | – | |
| 23 | XOMA ROYALTY CORPORATION | 1.2% | $9.4m | 300,000 | – | ||
| 24 | QTTB Q32 BIO INC | 1.1% | $8.1m | 1,256,228 | – | ||
| 25 | MBX MBX BIOSCIENCES INC | Healthcare | 1.0% | $7.8m | 260,000 | – | |
| 26 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 0.9% | $6.5m | 935,000 | – | |
| 27 | CGON CG ONCOLOGY INC | Healthcare | 0.8% | $6.4m | 94,800 | – | |
| 28 | JBIO JADE BIOSCIENCES INC | Healthcare | 0.8% | $6.0m | 427,608 | – | |
| 29 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.7% | $5.1m | 600,000 | – | |
| 30 | AH30 ASSERTIO HOLDINGS INC | 0.7% | $5.1m | 265,707 | – | ||
| 31 | EDIT EDITAS MEDICINE INC | Healthcare | 0.6% | $4.8m | 1,926,997 | – | |
| 32 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.6% | $4.7m | 190,671 | – | |
| 33 | DERM JOURNEY MED CORP | 0.6% | $4.5m | 960,000 | – | ||
| 34 | VYGR VOYAGER THERAPEUTICS INC | Healthcare | 0.6% | $4.4m | 1,150,000 | – | |
| 35 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.5% | $4.1m | 345,100 | – | |
| 36 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.5% | $3.8m | 123,000 | – | |
| 37 | CABA CABALETTA BIO INC | Healthcare | 0.5% | $3.7m | 1,380,000 | – | |
| 38 | BDSX BIODESIX INC | 0.5% | $3.5m | 238,047 | – | ||
| 39 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.5% | $3.4m | 955,000 | – | |
| 40 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 0.4% | $3.3m | 1,412,656 | – | |
| 41 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.4% | $3.1m | 245,000 | – | |
| 42 | FBIO FORTRESS BIOTECH INC | 0.4% | $2.9m | 1,042,000 | – | ||
| 43 | IRD OPUS GENETICS INC | 0.3% | $2.3m | 1,120,000 | – | ||
| 44 | RIGL RIGEL PHARMACEUTICALS INC | 0.2% | $1.9m | 70,000 | – | ||
| 45 | AVIR ATEA PHARMACEUTICALS INC | Healthcare | 0.2% | $1.7m | 322,600 | – | |
| 46 | LYEL LYELL IMMUNOPHARMA INC | 0.2% | $1.6m | 79,097 | – | ||
| 47 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.2% | $1.6m | 125,000 | – | |
| 48 | NXTC NEXTCURE INC | 0.2% | $1.5m | 141,181 | – | ||
| 49 | FDMT 4D MOLECULAR THERAPEUTICS IN | Healthcare | 0.1% | $1.0m | 112,291 | – | |
| 50 | PERSPECTIVE THERAPEUTICS INC | 0.1% | $834.0k | 200,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.